SC 13G Filing

Company

SELLAS Life Sciences Group, Inc.

Filed

August 5, 2009

Accession Number

0000929638-09-001300

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →